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Abstract
Substance Abuse Treatment, Prevention, and Policy (SATPP) is an open access, peer-reviewed
international journal of original research and scholarship that focuses on policy issues in the
treatment and prevention of substance use disorders. Separate and often disparate public systems
deal with substance use problems as well as provide treatment and prevention. This journal will
provide an environment for the exchange of ideas, new research, consensus papers, and critical
reviews that bridge fields that share a common goal of reducing the problems caused by drugs and
alcohol. The agenda is simple; a new forum for integrating thoughts, issues, and developments.
Separate and often disparate public systems deal with sub-
stance abuse as well as provide substance abuse treatment
and prevention. These include: legislation pertaining to
substance abuse; correctional supervision of substance
abusers; medical treatment and screening; mental health
services; research and evaluation of substance abuse pro-
grams; interdiction efforts, and so on. These varied sys-
tems share a common goal – to reduce the burden of
substance abuse on the abuser, their family, and society.
Unfortunately, these systems often operate in isolation of
one another. This journal will provide an environment for
the exchange of ideas, new research, consensus papers,
and critical reviews that bridge fields that share a common
goal of reducing the problems caused by substance abuse.
What kinds of papers interest us?
We are interested in articles on research and evaluation of
issues pertaining to treatment, recovery, and prevention,
but with an emphasis on items such as: evidence-based
practices; stigma reduction; how public policy and law
making have implications for treatment and recovery;
removing barriers to treatment and recovery; how deci-
sion makers can implement new treatment practices; and
the epidemiological trends in substance abuse in special
populations (e.g., corrections offenders, women, elders).
We will consider original data driven articles, consensus
topics, literature reviews – all with a policy flavor. These
papers may come from, but are not limited to, psychol-
ogy, psychiatry, sociology, medicine, social work, law,
forensics, corrections, education, health policy, and pub-
lic health.
There are many potential papers that go unpublished in
the scholarly literature that can find a home here. For
example, the Robert Woods Johnson Foundation "Sub-
stance Abuse Policy Research Program" funds a very large
number of projects that would yield perfectly relevant and
potentially publishable findings http://www.rwjf.org/
files/publications/annual/2004/
portfolio_addiction_01.jsp.
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Governmental agencies also receive large numbers of
reports such as program evaluations, some brand of cost-
benefit analysis, and position papers regarding substance
abuse, a portion of which are relevant and excellent. For
example, independent units submit many data driven
reports a year, usually to state agencies, most of which
have policy relevance. My guess is that many agencies
receive an abundance of policy-related reports. The task
here will be to solicit groups to submit high quality pub-
lications based on these reports. Finally, we purposefully
included prevention into our mix since this is a highly
untapped area. Broadening the scope a bit, most papers
on substance abuse, with the exception of wet lab-work,
have policy relevance because of the current social mar-
ginalizing disposition of substance use.
Our interest in policy is international and definitely not
confined to U.S. policies. It is very true that the current
public policy on substance use and abuse in the US is dif-
ferent from many parts of the world. However, having
region specific papers, U.S. and others, may be of general
interest. An international discussion will enrich the jour-
nal's content. Furthermore, policies in one country affect
policies elsewhere.
What do we mean by policy?
We envision the term "policy" to be broad and not just
public, governmental, or legal policy. Policies include
issues with clinical practice, the definitions of abuse, cul-
tural perspectives (e.g., regarding stigma, language, par-
ity), or other issues. For example, a current policy in the
practice of treatment may be for individuals to undergo a
detoxification (detox) period of about three days. This
practice likely comes from alcohol addiction and allows
treatment staff to closely monitor the person during the
time when delirium tremens or seizure might occur. The
three-day time period may not apply to other substances
of abuse (e.g., marijuana, stimulants) but in practice the
detox period remains the same. It would be interesting for
someone to review the purpose of the detox period or
even review how detox is done in other regions or situa-
tions. Another policy example regards the separation of
substance abuse treatment from mental health treatment.
That separation is widely prevalent in the US and likely
occurs elsewhere, too. More generally, governmental and
healthcare system policies affect the delivery, access, and
process of both treatment and prevention.
Policies also affect our definitions of abuse (DSM IV; the
American Psychiatric Association's Diagnostic and Statis-
tical Manual of Mental Disorders) or harmful/hazardous
use (ICD 10; the World Health Organization's Interna-
tional Classification of Diseases), since policies can create
the negative consequences. The consequences can vary
from mild social disapproval, loss of employment, or
incarceration and vilification. Few other medical diag-
noses appearing in DSM or ICD have this distinction.
So, we welcome you to Substance Abuse Treatment, Preven-
tion, and Policy. The journal will strive for impartiality and
fast turn around time. An open access mechanism partic-
ularly fits the journal's needs by broadening our reader-
ship throughout the world as well as speeding the
dissemination of manuscripts. We are proud of our edito-
rial board, which represent a very wide group of individu-
als from numerous disciplines and regions. The agenda is
simple, a new forum for integrating thoughts, issues, and
developments.